NO982100L - Peptid-derivater av Dolastatin 15 og deres anvendelse - Google Patents

Peptid-derivater av Dolastatin 15 og deres anvendelse

Info

Publication number
NO982100L
NO982100L NO982100A NO982100A NO982100L NO 982100 L NO982100 L NO 982100L NO 982100 A NO982100 A NO 982100A NO 982100 A NO982100 A NO 982100A NO 982100 L NO982100 L NO 982100L
Authority
NO
Norway
Prior art keywords
dolastatin
peptide derivatives
new
formula
preparation
Prior art date
Application number
NO982100A
Other languages
English (en)
Other versions
NO982100D0 (no
Inventor
Andreas Kling
Bernd Janssen
Wilhelm Amberg
Andreas Haupt
Kurt Ritter
Ernst Buschmann
Harald Bernard
Stefan Mueller
Thomas Zierke
Teresa Barlozzari
Monika De Arruda
Simon Robinson
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO982100L publication Critical patent/NO982100L/no
Publication of NO982100D0 publication Critical patent/NO982100D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nye peptider med formelen A-B-D-E-F-L hvori A, B, D, E, F og L har betydningene som er angitt i beskrivelsen, og deres fremstilling er beskrevet. De nye forbindelser er egnet for kontrollering av sykdommer.
NO982100A 1995-11-09 1998-05-08 Peptid-derivater av Dolastatin 15 og deres anvendelse NO982100D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/554,897 US5807984A (en) 1995-11-09 1995-11-09 Oligopeptides, the preparation and use thereof
PCT/EP1996/004709 WO1997017364A1 (en) 1995-11-09 1996-10-30 Peptide derivatives of dolastatin 15 and their use

Publications (2)

Publication Number Publication Date
NO982100L true NO982100L (no) 1998-05-08
NO982100D0 NO982100D0 (no) 1998-05-08

Family

ID=24215159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982100A NO982100D0 (no) 1995-11-09 1998-05-08 Peptid-derivater av Dolastatin 15 og deres anvendelse

Country Status (12)

Country Link
US (1) US5807984A (no)
EP (1) EP0859786A1 (no)
JP (1) JPH11515032A (no)
KR (1) KR19990067460A (no)
AU (1) AU729333B2 (no)
BR (1) BR9611383A (no)
CZ (1) CZ139198A3 (no)
HU (1) HUP9900089A3 (no)
MX (1) MX9803662A (no)
NO (1) NO982100D0 (no)
WO (1) WO1997017364A1 (no)
ZA (1) ZA969402B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
JP2001517604A (ja) * 1997-09-24 2001-10-09 アリゾナ ボード オブ リーゼンツ ドラスタチン１５から誘導された合成アンチネオプラスチック剤とその製造方法
US6686445B1 (en) 1997-09-24 2004-02-03 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
FR2774989B1 (fr) * 1998-02-18 2000-03-17 Adir Nouveaux cytotoxiques derives de l'oestradiol
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
CA3230737A1 (en) 2021-09-03 2023-03-09 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DE69230824T2 (de) * 1991-08-09 2000-07-27 Teikoku Hormone Mfg Co Ltd Neue tetrapeptidderivate
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
JP3523253B2 (ja) * 1992-05-20 2004-04-26 アボット ゲーエムベーハー ウント カンパニー カーゲー ドラスタチン誘導体
PL178766B1 (pl) * 1992-12-16 2000-06-30 Basf Ag Nowe peptydy
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides

Also Published As

Publication number Publication date
AU7495796A (en) 1997-05-29
JPH11515032A (ja) 1999-12-21
ZA969402B (en) 1998-05-08
HUP9900089A2 (hu) 1999-05-28
EP0859786A1 (en) 1998-08-26
HUP9900089A3 (en) 1999-11-29
US5807984A (en) 1998-09-15
AU729333B2 (en) 2001-02-01
WO1997017364A1 (en) 1997-05-15
NO982100D0 (no) 1998-05-08
CZ139198A3 (cs) 1998-09-16
MX9803662A (es) 1998-09-30
KR19990067460A (ko) 1999-08-16
BR9611383A (pt) 1999-01-26

Similar Documents

Publication Publication Date Title
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
FI961621A (fi) Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit
NO965412D0 (no) Nye trombin-inhibitorer, deres fremstilling og bruk
MX9706069A (es) Nuevos inhibidores de la trombina.
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
NO975710L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO995006L (no) Nye forbindelser
NO990662L (no) Trombin-inhibitorer
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
DK0553890T3 (da) Diphenylheteroalkylderivater, deres fremstilling og lægemidler og kosmetisk fremstillet derudfra
NO982100L (no) Peptid-derivater av Dolastatin 15 og deres anvendelse
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO971625L (no) Nye peptider med immunomodulatoriske effekter
ATE226592T1 (de) Peptide, die metallproteinasen und die tnf- freisetzung hemmen, und ihre therapeutische verwendung
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
NO973230L (no) Nye peptider, deres fremstilling og anvendelse
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69528855D1 (de) Pyrazolin-Derivate zur Bekämpfung von Pflanzenkrankheiten
NO982105L (no) Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider
NO20004613L (no) FremgangsmÕte for fremstilling av et tetrapeptid
EP0780472A3 (en) Stress proteins
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
AU6416696A (en) Substituted 1,3-dioxan-5-ylamino heterocyclic compounds, processes for their preparation and their use as pest control compositions
YU34693A (sh) Polipeptidi blokatori prolaza kalcijuma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application